News
This issue of the CRS Newsletter contains a fascinating summary of five published articles that have some focus on animals as a source of compounds with the potential to treat human conditions or as models to facilitate understanding of disease and biological functions. Of particular interest are…
I jotted notes for this update as I flew back from the Partnership Opportunities for Drug Delivery (PODD) conference in Boston. CRS was well represented at this conference. The conference, now in its fourth year, was again chaired by Board of Scientific Advisors (BSA) member Barbara Lueckel.…
Samir Mitragotri is a prominent leader in the field of drug delivery and biomaterials. His contribution in the field of transdermal drug delivery was noticed by the community when his group successfully published the delivery of vaccines (proteins), insulin (peptides), and siRNA via skin into the…
Introduction
Ile-Pro-Pro (IPP) is a bioactive peptide found in bovine milk when casein is hydrolyzed by gastrointestinal enzymes. It has an angiotensin-converting enzyme inhibitory potency of 5µM with the potential to reduce blood pressure, if orally administered.1 Although IPP is stable in…
Agis KydonieusAgis Kydonieus is the founder and president of Samos Pharmaceuticals LLC and cofounder of KAT Transdermals LLC and InteguRx Therapeutics LLC. He has 30+ years of extensive experience in preclinical as well as phase I–III clinical development and has launched several products in the…
Introduction
Microorganisms are contributing to a great degree nowadays in the field of biotechnology, with increasing demand as they provide a wide range of by-products that show promising economic importance and value in many specialized branches of…
